drugset / Trial / NCT00663273

Safety Dermatological Evaluation: Acceptability With Gynecological Follow up - Dermacyd Tina Gel Sweet Flower

NCT00663273

Phase 3 Completed 30 enrolled Sanofi
Non-randomizedSingle-groupOpen-labelSupportive care

Summary

The purpose of this study is to demonstrate the safety of the gynecological formulation in normal and usual usage condition of Dermacyd Tina Gel Sweet Flower.

Timeline

Start
2007-12
Primary completion
2008-01
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Lactic Acid Other / unclassified Topical

Indications

No indication recorded.